Nahariya, Israel

Idan Haika

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biosense Webster (Israel) Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Idan Haika. Retrieved from https://idiyas.com/inventor/idan-haika

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Idan Haika: Medical Instrument Tracking Innovation.

Introduction

Idan Haika is an inventor associated with Nahariya, Israel. His work includes an invention designed to help position-tracking systems manage signals from multiple medical instruments.

Latest Patents

Haika is credited with 1 patent: “Smart Port Splitter for Multiple Medical Instruments.” The apparatus receives position signals from multiple instruments inside a patient’s organ and forwards selected signals to a position-tracking system. Using control signals returned by that system, its switching circuitry can identify an instrument within the system’s working volume and change its switching scheme to forward all position signals from that instrument.

Career Highlights

Haika has been associated with Biosense Webster (Israel) Ltd. and Biosense Webster, Inc. His patent reflects work on signal routing and instrument tracking in medical applications.

Collaborations

His listed coworkers include Lior Zaritzky and Rustam Kostenko.

Conclusion

Idan Haika’s patent addresses the coordination of medical-instrument position signals, supporting more targeted tracking through an adaptive switching approach.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…